TABLE 3.

MIC data for Australian clinical Elizabethkingia anophelis isolates against clinically relevant antimicrobials

^aMIC data derived from broth microdilution testing of the 16 Australian clinical E. anophelis isolates against 39 clinically relevant antimicrobials. Pharmacokinetic-pharmacodynamic (non-species-specific) breakpoints applied from EUCAST clinical breakpoint tables (version 9.0) are shown in columns with yellow shading, and non-Enterobacteriaceae breakpoints applied from CLSI M100-29 (2019) are shown in columns with blue shading. Shaded blue and yellow cells indicate that no breakpoint is currently available for this antimicrobial within these schemes. S, susceptible; I, susceptible with high exposure (EUCAST definition) or intermediate (CLSI definition); R, resistant.

^bTazobactam concentration fixed at 4 mg/liter.

^cClavulanic acid concentration fixed at 2 mg/liter.

^dSulbactam concentration fixed at 4 mg/liter.